{"id":5536,"date":"2023-08-30T18:19:16","date_gmt":"2023-08-30T17:19:16","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=5536"},"modified":"2024-06-03T11:45:05","modified_gmt":"2024-06-03T10:45:05","slug":"cofepris-authorizes-new-influenza-vaccine-for-seniors","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/","title":{"rendered":"Cofepris authorizes new influenza vaccine for seniors"},"content":{"rendered":"<\/p>\n<p><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Cofepris, Mexico&#8217;s regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies. Of the more than one hundred new health registrations, 14 correspond to medicines, of which two new molecules stand out: a high-dose tetravalent anti-influenza vaccine subtypes A and B for people over 65 years of age, and a platelet antiaggregant.<\/span><\/p>\n<p><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Seven clinical trials were also authorized; of these, two are for the treatment of systemic lupus erythematosus and one for chronic renal transplant rejection. <a href=\"https:\/\/bit.ly\/3OnWYUj\">Read more here<\/a><\/span><\/p>\n<p><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">If you need more information on drug regulatory issues ELS can certainly help you with our registration services for your products.<\/span><\/p>\n<p class=\"p1\">Please contact your <a href=\"https:\/\/els-solutions.com\/en\/where-are-we\/\"><span class=\"s1\">ELS local consultant <\/span><\/a>or through the email: <a href=\"mailto:info@elssolutions.pt\"><span class=\"s2\">info@elssolutions.pt<\/span><\/a><\/p>\n<p>\n","protected":false},"excerpt":{"rendered":"<p>Cofepris, Mexico&#8217;s regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies.<\/p>\n","protected":false},"author":9,"featured_media":5527,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[54,61],"tags":[62],"class_list":["post-5536","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-news","tag-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cofepris - New influenza vaccine for seniors<\/title>\n<meta name=\"description\" content=\"Cofepris, Mexico&#039;s regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cofepris authorizes new influenza vaccine for seniors\" \/>\n<meta property=\"og:description\" content=\"Cofepris, Mexico&#039;s regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T17:19:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-03T10:45:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Cofepris authorizes new influenza vaccine for seniors\",\"datePublished\":\"2023-08-30T17:19:16+00:00\",\"dateModified\":\"2024-06-03T10:45:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/\"},\"wordCount\":843,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png\",\"keywords\":[\"News\"],\"articleSection\":[\"General\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/\",\"url\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/\",\"name\":\"Cofepris - New influenza vaccine for seniors\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png\",\"datePublished\":\"2023-08-30T17:19:16+00:00\",\"dateModified\":\"2024-06-03T10:45:05+00:00\",\"description\":\"Cofepris, Mexico's regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png\",\"width\":1200,\"height\":600,\"caption\":\"Cofepris new vaccine for seniors\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cofepris authorizes new influenza vaccine for seniors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/en\/#website\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cofepris - New influenza vaccine for seniors","description":"Cofepris, Mexico's regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Cofepris authorizes new influenza vaccine for seniors","og_description":"Cofepris, Mexico's regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies.","og_url":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2023-08-30T17:19:16+00:00","article_modified_time":"2024-06-03T10:45:05+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png","type":"image\/png"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Cofepris authorizes new influenza vaccine for seniors","datePublished":"2023-08-30T17:19:16+00:00","dateModified":"2024-06-03T10:45:05+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/"},"wordCount":843,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png","keywords":["News"],"articleSection":["General","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/","url":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/","name":"Cofepris - New influenza vaccine for seniors","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png","datePublished":"2023-08-30T17:19:16+00:00","dateModified":"2024-06-03T10:45:05+00:00","description":"Cofepris, Mexico's regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png","width":1200,"height":600,"caption":"Cofepris new vaccine for seniors"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/en\/cofepris-authorizes-new-influenza-vaccine-for-seniors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cofepris authorizes new influenza vaccine for seniors"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/en\/#website","url":"https:\/\/els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=5536"}],"version-history":[{"count":1,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5536\/revisions"}],"predecessor-version":[{"id":6550,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5536\/revisions\/6550"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media\/5527"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=5536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/categories?post=5536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/tags?post=5536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}